leishmaniasis

This Week in PLOS

In PLOS this week: gut microbial communities of Kenyan children, transcriptional patterns in model of visceral leishmaniasis infection, and more.

This Week in PLOS

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Genetic and immune profiles from Brazilian leishmaniasis cases suggest parasite strain and inflammatory cytokine may contribute to unusual forms of the disease.

In Nucleic Acids Research this week: software package to fix RNA-seq alignment artifacts, differential gene expression profiles of infectious Leishmania, and more.

NEW YORK (GenomeWeb News) – The international non-profit Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) will collaborate to screen for and examine molecules that may be used as new treatments for certain "neglected" diseases, IP-K said today.

The assay was developed by the Army Medical Research and Materiel Command in collaboration with the Walter Reed Army Institute of Research and Cepheid under a collaboration begun in 2005.

The Smart Leish PCR assay is a qualitative real-time PCR test for diagnosing individuals with cutaneous leishmaniasis caused by certain species of sand flies.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.